News

Stakeholder Partnerships Optimize ESRD Management & Prevention

May 2021

End Stage Renal Disease (ESRD), a state of kidney failure in which dialysis or kidney transplant is required to sustain life, is among the costliest chronic diseases. Historically, individuals with ESRD have been covered by fee-for-service Medicare after a 30-month waiting period. Spending on individuals with ESRD represents 7 percent of CMS spending. Beginning in…

Read more

Drugs are Overpriced According to the ICER Framework

May 2021

The Institute of Clinical and Economic Review (ICER) emerged as a critical voice in evaluating value-based price (VBP) benchmarks for drug pricing. However, despite its growing presence in the life sciences industry, the organization’s magnitude of impact on drug pricing is currently unknown. ISPOR conducted a retrospective review of 34 ICER Final reports from November…

Read more

Understanding the Future of APMs and MIPs

May 2021

The new Director of the Center for Medicare and Medicaid Innovation (CMMI), Liz Fowler, recently stated that the healthcare system is at a “critical juncture in the path to value-based care.” At the beginning of 2021, CMS placed five payment models under review, delaying or pausing their implementation, and announced that it is no longer…

Read more

NQF Action Brief on Opportunities for Advancing Adult Immunization Through Quality Measurement

May 2021

Adult vaccination rates in the U.S. lag goals. The COVID pandemic has highlighted this issue in recent months, but there are also gaps in immunization rates for other conditions. Despite the ready availability of vaccines, tens of thousands of U.S. adults die each year from vaccine-preventable diseases. In April, the National Quality Forum released a…

Read more

CMS Measures Under Consideration List Deadlines

April 2021

If the old saying of how to get to Carnegie Hall is “practice, practice, practice,” then how you might get a measure added to a federal health program could be “MUC, MUC, MUC.” The Measures Under Consideration (MUC) is a vetted list based on measurement priorities and is put before stakeholders and the measurement community…

Read more

How the Medicaid Final Rule May Affect Value Based Arrangements

April 2021

In the waning hours of the Trump administration, Seema Verma and other top Centers for Medicare & Medicaid Services (CMS) officials penned a blog in Health Affairs outlining key areas where the administration had advanced accountability by moving beyond fee-for-service payment. One particular action of note was a final rule issued Dec 31, 2020 that…

Read more

Adjusting Quality Measures for Social Risk Adjustment to Promote Healthcare Equity

April 2021

In April’s Health Affairs, Nerenz et al., note that of lack of consensus around social risk adjustment of quality measures is becoming a concern, given the expansion of CMS’s Quality Payment Program. The inclusion of individual physicians and physician groups and other clinicians in value-based payment has raised awareness about potential biases against safety-net providers,…

Read more

Impact of COVID on Quality Measures & Programs

April 2021

COVID-19 has been the greatest global public health challenge in the last century, and has been hugely impactful domestically, with more than 550,000 reported deaths, representing the third leading cause of death in 2020. The impact of this crisis across the value landscape has been nuanced. In some cases, COVID-19 has accelerated the pace of…

Read more

Advisory Panel Recommends New US Institute for Health Technology Assessment

April 2021

With continuing concerns about high and rising healthcare costs in the US, in the Spring of 2019, the USC Schaeffer Center collaborated with Aspen Institute to establish a 21-member stakeholder advisory panel to develop policy recommendations on the future of value assessment in the US. Anticipating a potential change of the political winds in 2021,…

Read more

How Oncology Clinicians Learn and Share on Social Media

April 2021

Social media is a powerful tool that oncology clinicians increasingly use to access emerging clinical evidence, engage with patients, and learn about experiences from the field. However, like any tool, it must be used deliberately, with an understanding of its limitations, to maximize benefits and avoid undesirable effects. This second blog in Discern Health’s Journal…

Read more

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO